reMYND is a Belgium-based biotechnology company that develops and commercializes therapies for the treatment of diabetes and Alzheimer's diseases.
Business Model:
Revenue: $0
Employees: 11-50
Address: Gaston Geenslaan 1
City: Leuven
State: flemish brabant
Zip: 3001
Country: BE
reMYND is a Belgium-based biotechnology company that develops and commercializes therapies for the treatment of diabetes and Alzheimer's diseases.
Contact Phone:
+13216751420
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2021 | Series B | $0 |
BNP Paribas Fortis FPIM Korys PMV University of Leuven BNP Paribas Fortis FPIM Korys PMV University of Leuven |
12/2018 | Series B | 7 | $13.7M |
BNP Paribas Fortis Bernard Majoie Christoph Waer Gemma Frisius Fund Korys PMV University of Leuven Bernard Majoie BNP Paribas Fortis Christoph Waer Gemma Frisius Fund Korys PMV University of Leuven |
12/2008 | Grant | $1.3M | 1/2021 | Series B | $14.6M |
Korys Investments FPIM KU Leuven PMV BNP Paribas Fortis Private Equity |
12/2018 | Series B | $13.6M | 1/2021 | Series B | 5 | $14.6M |
BNP Paribas Fortis FPIM Korys PMV University of Leuven BNP Paribas Fortis FPIM Korys PMV University of Leuven |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|